APA (7th ed.) Citation

Jurmeister, P., Weber, K., Villegas, S., Karn, T., Untch, M., Thieme, A., . . . Capper, D. (2021). DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status. Clinical epigenetics, 13, . https://doi.org/10.1186/s13148-021-01176-5

Chicago Style (17th ed.) Citation

Jurmeister, Philipp, et al. "DNA Methylation Profiling Identifies Two Distinct Subgroups in Breast Cancers with Low Hormone Receptor Expression, Mainly Associated with HER2 Amplification Status." Clinical Epigenetics 13 (2021). https://doi.org/10.1186/s13148-021-01176-5.

MLA (9th ed.) Citation

Jurmeister, Philipp, et al. "DNA Methylation Profiling Identifies Two Distinct Subgroups in Breast Cancers with Low Hormone Receptor Expression, Mainly Associated with HER2 Amplification Status." Clinical Epigenetics, vol. 13, 2021, https://doi.org/10.1186/s13148-021-01176-5.